The unique profile of myc-activated genes in MM, as compared to MGUS, suggests that myc during the transformation process may still represent a secondary genetic lesion in cells already hit by a primary event, i.e. IgH translocations or cyclin D1 activation (4). This evidence concerns the gene CCND1 and Miyoshi myopathy.